홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Safety and efficacy of DOACs for non-cirrhotic splanchnic vein thrombosis: a single centre retrospective analysis | Synapse
March 3, 2026
Safety and efficacy of DOACs for non-cirrhotic splanchnic vein thrombosis: a single centre retrospective analysis
LD
Luca Depietri
FF
Filippo B. Fabbri
MV
Maria Rosaria Veropalumbo
See all
Key Points
Efficacy of direct oral anticoagulants (DOACs) was confirmed for treating non-cirrhotic splanchnic vein thrombosis, enhancing patient care.
In this analysis, 75% of patients experienced resolution of thrombosis after three months of DOAC treatment.
Retrospective analysis highlighted safety outcomes, with minimal bleeding events reported among patients treated with DOACs.
These findings suggest that DOACs may provide an effective and safe option for managing splanchnic vein thrombosis.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Depietri et al. (Sat,) studied this question.
synapsesocial.com/papers/69a75a09c6e9836116a1f874
https://doi.org/https://doi.org/10.1007/s00228-025-03966-9